NCT00004658View on ClinicalTrials.gov

Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1995

Conditions
5'-Nucleotidase Syndrome
Interventions
DRUG

ribose

DRUG

thymidine

DRUG

uridine

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004658 - Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity | Biotech Hunter | Biotech Hunter